172@29@16@14!~!172@29@0@53!~!|stocks|company_info|stock_news.php?sc_id=P&durationType=Y&Year=2005!~!www|moneycontrol|com!~!|stocks|company_info|stock_news.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Pfizer

Pfizer

BSE: 500680|NSE: PFIZER|ISIN: INE182A01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 16, 16:00
4970.85
2.35 (0.05%)
VOLUME 1,246
LIVE
NSE
Oct 16, 15:58
4974.05
6.15 (0.12%)
VOLUME 17,182
News on Pfizer
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Pfizer proposes new launches

9.30 am | 22 Dec 2005

Pfizer Ltd, which is restructuring its products, plans to grow in the Indian market by launching new drugs from the parent company's portfolio and thr...

Pfizer launches Viagra in India

9.33 am | 21 Dec 2005

It was just an idea in 1989 when Pfizer's Dr Peter Ellis, joint patent holder on Viagra, thought that sildenafil citrate could be effective in treatin...

Will appeal decision, take it to Federal Circuit: Ranbaxy

10.00 am | 19 Dec 2005

Ranbaxy suffered yet another setback as a US court on Friday upheld the validity of two key US patents on Pfizer's Lipitor. But President of Ranbaxy M...

Ranbaxy loses out to Pfizer again?

10.44 am | 17 Dec 2005

A US court yesterday upheld the validity of two key US patents on Pfizer's Lipitor. This is a major setback to Ranbaxy which had hoped to introduce a ...

Indian firms should focus on R&D: Pfizer

9.02 am | 28 Nov 2005

Ranbaxy's challenge to Pfizer's blockbuster cholesterol lowering drug-Lipitor has grabbed headlines in recent weeks. Expectedly, Pfizer believes that ...

US Appeals Court upholds ruling against Ranbaxy

11.07 am | 23 Nov 2005

The US Appeals Court has upheld its injunction against Ranbaxy in the Quinapril patent case, the court has also ruled against Teva in the Quinapril pa...

Ranbaxy wins Atorvastatin process patent in Norway

10.16 am | 10 Nov 2005

Ranbaxy has won the Atorvastatin process patent in Norway. It will also appeal the court ruling on intermediate compound patent. ...

UK court blocks Ranbaxy's generic copy of Lipitor

8.46 am | 13 Oct 2005

A British court has upheld one of the two key patents on Pfizer's top-selling drug Lipitor, blocking Ranbaxy from launching a generic copy of the drug...

UK ruling for Lipitor to indicate US ruling: Analysts

3.25 pm | 07 Oct 2005

The UK Court will give its verdict on the Lipitor case next week. Analysts say that UK is not a very big market for Lipitor. However, a lot of market ...

GSK Pharma tops domestic mkt in Aug: ORG-IMS

3.41 pm | 03 Oct 2005

According to the latest study conducted by ORG-IMS, GSK Pharma tops domestic market with 5.9% share, followed by Cipla with 5.3% share in August on MA...

Cut positions in Dr Reddy's Labs, Pfizer, says Baliga

11.49 am | 29 Sep 2005

Ambareesh Baliga of Karvy Stock Broking says that they have been cutting positions in Dr Reddy's Labs and Pfizer....

Pfizer Q3 net profit up at Rs 21.82cr

3.46 pm | 26 Sep 2005

Pfizer has announced its third quarter results. The company's Q3 net profit is up at Rs 21.82 crore as against Rs 13.44 crore....

ADRs to fund Ranbaxy's future acquisitions

2.52 pm | 05 Sep 2005

The Ranbaxy board is expected to meet on September 9 to discuss listing on the US Stock Exchange. The board will also consider conversion of its Globa...

Ranbaxy challenges Pfizer over cholestrol drug

11.33 am | 03 Sep 2005

India's leading drug maker Ranbaxy has challenged the global pharma major Pfizer over the world's largest selling drug Lipitor. As the day of judgemen...

Will never sell stake in Cipla: Yusuf Hamied

3.33 pm | 29 Aug 2005

Yusuf Hamied, Chairman, Cipla has confirmed that he will never go ahead with any stake sale as he wants to retain Cipla as a total Indian company. ...

Ranbaxy opens facility for drug discovery

9.16 am | 17 Aug 2005

Ranbaxy Laboratories has opened its third Research and Development, R&D, facility in Gurgaon. The new facility would focus on new drug discovery resea...

Pfizer Q2 net profit at Rs 15.47cr

5.28 pm | 28 Jun 2005

Pfizer has announced its Q2 results. Its net profit is at Rs 15.47 crore. ...

Buy Pfizer at current levels, says Shah

11.46 am | 04 May 2005

Jigar Shah is of the opinion that Pfizer will give good returns in long term. Investors should buy the stock now....

Pfizer India may help broadbase wonder drug

2.33 pm | 25 Apr 2005

Pfizer, the top global drug maker, has recently introduced in India its potent anti-fungal brand Vfend. Its Indian arm may play a pivotal role in fu...

Pfizer suspends sales of Bextra

8.31 pm | 07 Apr 2005

Pfizer Inc. agreed to suspend sales and marketing of the arthritis drug Bextra at the request of US drug regulators....

1 2
Quick Links for Pfizer
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.